The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Frontiers Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma

Frontiers Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer

Lung cancer in patients who have never smoked — an emerging disease

CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,identified using LC-SCRUM-Asia genomic screening platform - A step further to precision medicine

Novel mutations in a second primary gastric cancer in a patient treated for primary colon cancer, World Journal of Surgical Oncology

PDF) ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

Biomolecules, Free Full-Text

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

LTK fusions: A new target emerges in non-small cell lung cancer - ScienceDirect

Pharos : Target Details - LTK